JPS631924B2 - - Google Patents
Info
- Publication number
- JPS631924B2 JPS631924B2 JP16386479A JP16386479A JPS631924B2 JP S631924 B2 JPS631924 B2 JP S631924B2 JP 16386479 A JP16386479 A JP 16386479A JP 16386479 A JP16386479 A JP 16386479A JP S631924 B2 JPS631924 B2 JP S631924B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- ftorafur
- parts
- fatty acid
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 fatty acid ester Chemical class 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 10
- 239000000194 fatty acid Substances 0.000 claims description 10
- 229930195729 fatty acid Natural products 0.000 claims description 10
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- WFWLQNSHRPWKFK-UHFFFAOYSA-N Tegafur Chemical compound O=C1NC(=O)C(F)=CN1C1OCCC1 WFWLQNSHRPWKFK-UHFFFAOYSA-N 0.000 claims description 3
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 description 24
- 229960001674 tegafur Drugs 0.000 description 24
- 239000000047 product Substances 0.000 description 12
- 239000000829 suppository Substances 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16386479A JPS5686114A (en) | 1979-12-17 | 1979-12-17 | Pharmaceutical composition for suppository |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16386479A JPS5686114A (en) | 1979-12-17 | 1979-12-17 | Pharmaceutical composition for suppository |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5686114A JPS5686114A (en) | 1981-07-13 |
| JPS631924B2 true JPS631924B2 (OSRAM) | 1988-01-14 |
Family
ID=15782210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16386479A Granted JPS5686114A (en) | 1979-12-17 | 1979-12-17 | Pharmaceutical composition for suppository |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5686114A (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02173424A (ja) * | 1988-11-08 | 1990-07-04 | Uni Cardan Ag | 摩擦結合または制動の調整方法および該方法の実施装置 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578391A (en) * | 1982-01-20 | 1986-03-25 | Yamanouchi Pharmaceutical Co., Ltd. | Oily compositions of antitumor drugs |
| WO1989002732A1 (fr) * | 1987-09-25 | 1989-04-06 | Fujisawa Pharmaceutical Co., Ltd. | Solution huileuse pour instillation rectale |
-
1979
- 1979-12-17 JP JP16386479A patent/JPS5686114A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02173424A (ja) * | 1988-11-08 | 1990-07-04 | Uni Cardan Ag | 摩擦結合または制動の調整方法および該方法の実施装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5686114A (en) | 1981-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4722941A (en) | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof | |
| DE69720985T3 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
| Loeb et al. | Activity of a new antimalarial agent, chloroquine (SN 7618): Statement approved by the Board for coordination of malarial studies | |
| EP0178436B1 (de) | Ibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung | |
| EP0659410B1 (de) | Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen | |
| ES2117642T3 (es) | Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles. | |
| JPS63174922A (ja) | 有効成分の投与のための医薬製剤 | |
| UA59388C2 (uk) | Препарат, який містить парацетамол у вигляді таблетки для ковтання або капсули, та спосіб його виготовлення | |
| JPH07196512A (ja) | 医薬組成物 | |
| JPH02157220A (ja) | 徐放性坐剤 | |
| Beskid et al. | Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers | |
| JPS631924B2 (OSRAM) | ||
| JPS63406B2 (OSRAM) | ||
| CA1248524A (en) | Complexes of prostaglandins | |
| JP2010163428A (ja) | 崩壊錠 | |
| DE3602577A1 (de) | 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen | |
| JPH01121212A (ja) | 油性基剤の薬物放出用無水液状懸濁剤 | |
| JPS59148718A (ja) | ユビデカレノン組成物 | |
| US3852454A (en) | Treatment of rheumatoid arthritis | |
| US4146648A (en) | Chemotherapeutic composition | |
| PT94372A (pt) | Processo de producao de um sistema de distribuicao de droga em suspensao em liquido nao aquoso, a base de, entre outros, clorazepato dipotassico | |
| EP0009808A1 (en) | Composition having skeletal muscle relaxant activity | |
| JPH044300B2 (OSRAM) | ||
| JPH0136442B2 (OSRAM) | ||
| KR910018026A (ko) | α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제 |